统计剂的使用和强度对血液透析患者的死亡率的影响
Yunmee Lho1, Gui Ok Kim2, Bo Yeon Kim3
1Senotherapy-Based Metabolic Disease Control Research Center, Yeungnam University, Daegu 42415, Republic of Korea.
Pharmaceuticals (Basel, Switzerland)
|April 27, 2024
概括
这项针对血液透析患者的研究发现,与不使用他类药物相比,中度强度的他类药物使用与更好的生存率有关,即使考虑到患者差异. 高强度他类药物与较高的死亡率有关.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 关于他类药物强度对血液透析 (HD) 患者存活时间的影响的研究有限.
- 了解这种关联对于优化HD患者心血管风险管理至关重要.
研究的目的:
- 在大量维持血液透析患者中,评估患者存活率与他类药物强度相关.
- 为了调查不同的他类药物强度是否与这个特定的患者群体的不同死亡风险相关.
主要方法:
- 利用了来自全国性疾病疾病质量评估计划的数据,其中包括53,345名患者.
- 将患者分为四组:没有他类药物,低强度,中等强度和高强度的他类药物使用者.
- 采用单变量和多变量考克斯回归分析,包括对队列平衡的倾向性得分权重,以评估生存差异.
主要成果:
- 单变量分析最初表明,非他类药物使用者的生存率更好,这归因于年龄较小和并发症较少.
- 多变量和均衡的队列分析显示,与非使用者相比,中度强度他类药物组的患者存活率显著更高.
- 高强度他类药物使用与中度或低强度使用相比,与更高的死亡率有关.
结论:
- 尽管基线特征差异,但统计调整表明,中度强度的他类药物使用可能与血液透析患者的生存率改善有关.
- 这些发现凸显了中度他类药物治疗对提高这种高风险人群患者存活率的潜在益处.
- 需要进一步的研究来证实他类药物的强度与血液透析中的临床结果之间的强有力的关联.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
652
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:27Dialysis
302
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
302
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:17Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91